EMSURG
ActiveSummary
EMSURG has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €29,126 and a net result of €23,978. Its solvency ranks better than 69% of 16618 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability100=
Solvency100▲+32
Growth78
Track record82
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2,500 at 30 days acceptable
Liquidity ample (current ratio 4.98 against 1.75 in 2024; short-term debt: 20.1% and cash: 71.3% of total assets), and 20.1% of the assets are financed with debt.
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
79.9%
Return on assets
65.8%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-08-2026, 28 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 2 filingsDeviation from the deadline
2025
28 d late
2024
28 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
26-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit simulator What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed Roughly what is this company worth?Value indication
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Equity
€29,126▲ 387%
2024 · €5,980
Total assets
€36,436▲ 161%
2024 · €13,935
Net result
€23,978▲ 456%
2024 · €4,313
Working capital
€29,126▲ 387%
2024 · €5,980
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20242025
Operating result€5,392-€30,290▲ 462%
Net result€4,313-€23,978▲ 456%
Equity€5,980-€29,126▲ 387%
Total assets€13,935-€36,436▲ 161%
Debt€7,955-€7,311▼ 8.1%
Working capital€5,980-€29,126▲ 387%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result rises in 2025; 2025 is 462% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Equity and liabilities €36,436
Equity
€29,126 ▲ 387%
Debt
€7,311 ▼ 8.1%
Debt's share of the balance-sheet total falls from 57.1% to 20.1%. Equity is higher and debt is lower.
Key figures and ratios
Current ratio
4.98▲
2024 · 1.75
Debt to equity
0.25▼
2024 · 1.33
ROE
82.3%▲
2024 · 72.1%
ROA
65.8%▲
2024 · 31.0%
Debt ≤ 1 year
€7,311▼
2024 · €7,955
Income taxes
€6,112▲
2024 · €1,078
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Other operating charges640/8 | - | €380 | - |
| Gross operating margin9900 | €5,392 | €30,670 | ▲ 469% |
| Operating profit (loss)9901 | €5,392 | €30,290 | ▲ 462% |
| Financial charges65/66B | - | €199 | - |
| Recurring financial charges65 | - | €199 | - |
| Profit (loss) for the period before taxes9903 | €5,392 | €30,091 | ▲ 458% |
| Income taxes67/77 | €1,078 | €6,112 | ▲ 467% |
| Profit (loss) for the period9904 | €4,313 | €23,978 | ▲ 456% |
| Profit (loss) for the period to be appropriated9905 | €4,313 | €23,978 | ▲ 456% |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Assets | |||
| Total assets20/58 | €13,935 | €36,436 | ▲ 161% |
| Current assets29/58 | €13,935 | €36,436 | ▲ 161% |
| Amounts receivable within one year40/41 | €1,746 | €4,527 | ▲ 159% |
| Trade receivables40 | €1,746 | €4,527 | ▲ 159% |
| Cash at bank and in hand54/58 | €7,500 | €25,970 | ▲ 246% |
| Deferred charges and accrued income490/1 | €4,689 | €5,939 | ▲ 26.7% |
| Equity and liabilities | |||
| Total equity and liabilities10/49 | €13,935 | €36,436 | ▲ 161% |
| Equity10/15 | €5,980 | €29,126 | ▲ 387% |
| Contributions10/11 | €2,500 | €2,500 | = |
| Profit (loss) carried forward14 | €3,480 | €26,626 | ▲ 665% |
| Amounts payable17/49 | €7,955 | €7,311 | ▼ 8.1% |
| Amounts payable within one year42/48 | €7,955 | €7,311 | ▼ 8.1% |
| Trade debts44 | - | €225 | - |
| Suppliers440/4 | - | €225 | - |
| Taxes, remuneration and social security45 | €1,328 | €6,362 | ▲ 379% |
| Taxes450/3 | €1,328 | €6,362 | ▲ 379% |
| Other amounts payable47/48 | €6,627 | €724 | ▼ 89.1% |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Profit (loss) for the period9904 | €4,313 | €23,978 | ▲ 456% |
| Operating cash flow (approximation) | €4,313 | €23,978 | ▲ 456% |
| Change in cash | - | €18,470 | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
28-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 28 days late
2025
31-12
Financial
Liquidity triplescurrent ratio 4.98
Current ratio from 1.75 to 4.98; short-term debt falls from €7,955 to €7,311.
28-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 28 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
We have established no sitting directors for this company. We derive directors from published Gazette acts; while there are none, or none read, nothing appears here. That does not mean the company has none: the CBE keeps its own list of function holders, which we do not read.
Location & real-estate footprint
Registered office, Anderlecht · 1 establishment unit since 2024
Ground area
138 m²
Building footprint
69 m²
Volume, LiDAR
551 m³
Parcel 21308H0347/00V002, Brussels · tallest building 11.2 m, ±3 floors. Linked by address, not a title deed.
3
companies at this address
See who is registered here
1 establishment unit
EMSURG
since 20242.369.603.496
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21308H0347/00V002 | Brussels | 138 m² | 1 · 69 m² | 11.2 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
MaxUrgSi
BE 1028.307.589
Sombreffe · Eq €29,130
LDMO
BE 1029.255.122
Namur · Eq €29,075
HEA ophtalmologie
BE 0758.484.867
Lasne · Eq €29,070
Dr. Tjorven Audenaert, cardiologie
BE 0740.593.911
Aalter · Eq €29,191
BEST MED
BE 0696.725.957
Liège · Eq €29,198
Of 16,630 companies in sector 86220 we hold annual accounts for 7,981. 3,960 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded16-12-2024
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
Contact
E-mail
meriem.ennaji@gmail.comAnderlecht
Scores and ratios are computed by Checked and are not a credit decision.